BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36965240)

  • 21. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series.
    Kim MJ; Ko JS; Shin M; Hahn JW; Moon SY; Kim HY; Moon JS
    BMC Pediatr; 2021 Nov; 21(1):504. PubMed ID: 34763671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
    Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
    Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
    Lavelle A; Nancey S; Reimund JM; Laharie D; Marteau P; Treton X; Allez M; Roblin X; Malamut G; Oeuvray C; Rolhion N; Dray X; Rainteau D; Lamaziere A; Gauliard E; Kirchgesner J; Beaugerie L; Seksik P; Peyrin-Biroulet L; Sokol H
    Gut Microbes; 2022; 14(1):2078620. PubMed ID: 35638103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of colorectal cancer in inflammatory bowel diseases.
    Nadeem MS; Kumar V; Al-Abbasi FA; Kamal MA; Anwar F
    Semin Cancer Biol; 2020 Aug; 64():51-60. PubMed ID: 31112753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Burr NE; Hull MA; Subramanian V
    J Clin Gastroenterol; 2017 Mar; 51(3):247-253. PubMed ID: 26905603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
    Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
    J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease.
    Derikx LA; Smits LJ; van Vliet S; Dekker E; Aalfs CM; van Kouwen MC; Nagengast FM; Nagtegaal ID; Hoogerbrugge N; Hoentjen F
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):454-458.e1. PubMed ID: 27521512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
    Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
    Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
    Lewis JD; Abreu MT
    Gastroenterology; 2017 Feb; 152(2):398-414.e6. PubMed ID: 27793606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
    Azcárate-Peril MA; Sikes M; Bruno-Bárcena JM
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G401-24. PubMed ID: 21700901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.